Literature DB >> 33390656

Analysis of gene expression of prostaglandin EP4 receptor in canine osteosarcoma.

Margaret L Musser1, Austin K Viall1, Rachel L Phillips1, Jesse M Hostetter1, Chad M Johannes1.   

Abstract

In many human cancers, the expression of the prostaglandin receptor EP4 (EP4R) is associated with the development of malignancy and a poor prognosis. The expression of EP4R has not yet been evaluated in canine tumors. The objective of this study was to characterize the messenger RNA (mRNA) expression of EP4R in canine osteosarcoma (OSA). Gene expression of EP4R was evaluated using RNA in-situ hybridization (RNAscope). In all canine OSA samples evaluated, strong universal positive expression of EP4R was identified. Gene expression was significantly higher in OSA tissue samples than in normal nasal turbinate bone, possibly implicating EP4R in the pathogenesis of canine OSA. Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.

Entities:  

Year:  2021        PMID: 33390656      PMCID: PMC7747661     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  15 in total

1.  RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues.

Authors:  Fay Wang; John Flanagan; Nan Su; Li-Chong Wang; Son Bui; Allissa Nielson; Xingyong Wu; Hong-Thuy Vo; Xiao-Jun Ma; Yuling Luo
Journal:  J Mol Diagn       Date:  2012-01       Impact factor: 5.568

2.  Molecular cloning and functional characterization of the canine prostaglandin E2 receptor EP4 subtype.

Authors:  T A Castleberry; B Lu; S L Smock; T A Owen
Journal:  Prostaglandins Other Lipid Mediat       Date:  2001-07       Impact factor: 3.072

Review 3.  COX and cancer.

Authors:  D Mazhar; R Gillmore; J Waxman
Journal:  QJM       Date:  2005-10

Review 4.  International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.

Authors:  R A Coleman; W L Smith; S Narumiya
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

5.  Immunohistochemical expression of COX-2, mPGES and EP2 receptor in normal and reactive canine bone and in canine osteosarcoma.

Authors:  F Millanta; P Asproni; S Cancedda; M Vignoli; B Bacci; A Poli
Journal:  J Comp Pathol       Date:  2012-05-25       Impact factor: 1.311

Review 6.  The prostanoid EP4 receptor and its signaling pathway.

Authors:  Utako Yokoyama; Kousaku Iwatsubo; Masanari Umemura; Takayuki Fujita; Yoshihiro Ishikawa
Journal:  Pharmacol Rev       Date:  2013-06-17       Impact factor: 25.468

Review 7.  Breast cancer metastasis to the bone: mechanisms of bone loss.

Authors:  Yu-Chi Chen; Donna M Sosnoski; Andrea M Mastro
Journal:  Breast Cancer Res       Date:  2010-12-16       Impact factor: 6.466

Review 8.  Chronic immune activation and inflammation as the cause of malignancy.

Authors:  K J O'Byrne; A G Dalgleish
Journal:  Br J Cancer       Date:  2001-08-17       Impact factor: 7.640

Review 9.  Grapiprant: an EP4 prostaglandin receptor antagonist and novel therapy for pain and inflammation.

Authors:  Kristin Kirkby Shaw; Lesley C Rausch-Derra; Linda Rhodes
Journal:  Vet Med Sci       Date:  2015-12-21

10.  Fully Automated RNAscope In Situ Hybridization Assays for Formalin-Fixed Paraffin-Embedded Cells and Tissues.

Authors:  Courtney M Anderson; Bingqing Zhang; Melanie Miller; Emerald Butko; Xingyong Wu; Thomas Laver; Casey Kernag; Jeffrey Kim; Yuling Luo; Henry Lamparski; Emily Park; Nan Su; Xiao-Jun Ma
Journal:  J Cell Biochem       Date:  2016-06-06       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.